Back

The prognostic relevance of neutrophil-to-lymphocyte ratio in infective endocarditis for heart failure patients

11 May 2024 (08:00 - 20:00)
Organised by: Logo
Congress Presentation Part of: ePosters in valvular and pulmonary 3 Epidemiology, Prognosis, Outcome HFA Premium Access Heart Failure 2024 Heart Failure Association (HFA)

About the speaker

Photo
Doctor Rafaela Fernandes

Centro Hospitalar E Universitario De Coimbra, Coimbra (Portugal)

6 More presentations in this session

Presentation thumbnail
In-hospital mortality in infective endocarditis: a score comparison
Doctor J. Gouveia Fiuza (Viseu, PT)
Abstract Slides Video
Presentation thumbnail
Highlighting the importance of risk stratification and management in infective endocarditis
Doctor A. Garcia (Lisbon, PT)
Abstract Slides Video
Presentation thumbnail
Neurological complications in infective endocarditis: risk factors and outcome.
Doctor J. Mirinha Luz (Almada, PT)
Abstract Slides Video
Presentation thumbnail
The changing clinical trajectory of patients with valvular infective endocarditis during the SARS COV2 pandemic
Mrs R. Piriianu-Masgras (Bucuresti, RO)
Abstract Slides Video
Presentation thumbnail
Assessing the impact of evolving infective endocarditis epidemiology on heart failure patients: challenges and implications
Doctor R. Fernandes (Coimbra, PT)
Abstract Slides Video

Access the full session

Session thumbnail
ePosters in valvular and pulmonary 3

The Event

Event poster

Heart Failure 2024

11 May - 14 May 2024
You may be interested in
thumbnail
Congress Presentation
The neutrophil to lymphocyte ratio (NRL) as a predictor of nutritional status in patients with heart failure with reduced ejection fraction
thumbnail
Congress Presentation
Neutrophil-to-lymphocyte ratio (NLR) and mortality in heart failure: analysis of population-level data
thumbnail
Congress Presentation
Red blood cell distribution width and neutrophil-to-lymphocyte ratio: both potential predictors for adverse outcomes in patients with acute heart failure

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources